JP2014532395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532395A5 JP2014532395A5 JP2014536330A JP2014536330A JP2014532395A5 JP 2014532395 A5 JP2014532395 A5 JP 2014532395A5 JP 2014536330 A JP2014536330 A JP 2014536330A JP 2014536330 A JP2014536330 A JP 2014536330A JP 2014532395 A5 JP2014532395 A5 JP 2014532395A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- allergic
- medicament according
- amino acid
- polynucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 102000040430 polynucleotide Human genes 0.000 claims 9
- 108091033319 polynucleotide Proteins 0.000 claims 9
- 239000002157 polynucleotide Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 201000004624 Dermatitis Diseases 0.000 claims 4
- 208000010668 atopic eczema Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 206010014950 Eosinophilia Diseases 0.000 claims 3
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000004968 inflammatory condition Effects 0.000 claims 3
- 208000011580 syndromic disease Diseases 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 206010012442 Dermatitis contact Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 2
- 230000001363 autoimmune Effects 0.000 claims 2
- 230000009610 hypersensitivity Effects 0.000 claims 2
- 201000010659 intrinsic asthma Diseases 0.000 claims 2
- 206010028417 myasthenia gravis Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims 1
- 206010052613 Allergic bronchitis Diseases 0.000 claims 1
- 206010002198 Anaphylactic reaction Diseases 0.000 claims 1
- 208000028185 Angioedema Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010003645 Atopy Diseases 0.000 claims 1
- 206010006474 Bronchopulmonary aspergillosis allergic Diseases 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 206010015218 Erythema multiforme Diseases 0.000 claims 1
- 206010015866 Extravasation Diseases 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 claims 1
- 206010018258 Giant papillary conjunctivitis Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000004852 Lung Injury Diseases 0.000 claims 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 1
- 206010029379 Neutrophilia Diseases 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010053879 Sepsis syndrome Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 claims 1
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 claims 1
- 206010069363 Traumatic lung injury Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 208000037883 airway inflammation Diseases 0.000 claims 1
- 201000009961 allergic asthma Diseases 0.000 claims 1
- 208000006778 allergic bronchopulmonary aspergillosis Diseases 0.000 claims 1
- 208000002029 allergic contact dermatitis Diseases 0.000 claims 1
- 208000028004 allergic respiratory disease Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 230000036783 anaphylactic response Effects 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 206010069664 atopic keratoconjunctivitis Diseases 0.000 claims 1
- 230000005784 autoimmunity Effects 0.000 claims 1
- 201000009267 bronchiectasis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 208000018631 connective tissue disease Diseases 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 206010014599 encephalitis Diseases 0.000 claims 1
- 210000003038 endothelium Anatomy 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 230000002327 eosinophilic effect Effects 0.000 claims 1
- 201000009580 eosinophilic pneumonia Diseases 0.000 claims 1
- 230000036251 extravasation Effects 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 208000007475 hemolytic anemia Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000002919 insect venom Substances 0.000 claims 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 231100000225 lethality Toxicity 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 231100000515 lung injury Toxicity 0.000 claims 1
- 208000008585 mastocytosis Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 208000007892 occupational asthma Diseases 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 claims 1
- 208000036273 reactive airway disease Diseases 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 206010040400 serum sickness Diseases 0.000 claims 1
- 206010043554 thrombocytopenia Diseases 0.000 claims 1
- 231100000611 venom Toxicity 0.000 claims 1
- 208000034280 venom allergy Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1118201.1 | 2011-10-21 | ||
| GBGB1118201.1A GB201118201D0 (en) | 2011-10-21 | 2011-10-21 | Novel peptides |
| PCT/GB2012/052586 WO2013057499A1 (en) | 2011-10-21 | 2012-10-19 | Novel peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014532395A JP2014532395A (ja) | 2014-12-08 |
| JP2014532395A5 true JP2014532395A5 (https=) | 2015-08-27 |
| JP6199296B2 JP6199296B2 (ja) | 2017-09-20 |
Family
ID=45373221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014536330A Active JP6199296B2 (ja) | 2011-10-21 | 2012-10-19 | 新規ペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9320791B2 (https=) |
| EP (1) | EP2768850B1 (https=) |
| JP (1) | JP6199296B2 (https=) |
| CA (1) | CA2852381C (https=) |
| ES (1) | ES2770438T3 (https=) |
| GB (1) | GB201118201D0 (https=) |
| WO (1) | WO2013057499A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12358957B2 (en) | 2017-01-12 | 2025-07-15 | Revolo Biotherapeutics Limited | Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity |
| US12331088B2 (en) | 2017-01-12 | 2025-06-17 | Revolo Biotherapeutics Limited | Method for the treatment of a relapsing-remitting condition |
| GB201700557D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Novel peptides |
| GB201700555D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Method for the treatment of a relapsing-remitting condition |
| CN111944060B (zh) * | 2020-07-29 | 2022-02-25 | 中国农业大学 | 一种兼具抗菌、抗炎、解毒活性的多功能杂合肽及其应用 |
| EP4525906A1 (en) * | 2022-05-16 | 2025-03-26 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating food allergies |
| WO2024218571A1 (en) * | 2023-04-18 | 2024-10-24 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating eosinophilic esophagitis |
| WO2025037259A1 (en) * | 2023-08-15 | 2025-02-20 | Revolo Biotherapeutics Limited | Methods and compositions for preventing or treating severe asthma |
| WO2025255468A2 (en) | 2024-06-06 | 2025-12-11 | Miguel Guzman | Subcutaneous formulation of a peptide derived from chaperonin 60.1 |
| WO2026024894A2 (en) | 2024-07-24 | 2026-01-29 | De Alba Jorge | Sublingual formulations of a peptide derived from chaperonin 60.1 and related methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887481B1 (en) * | 1998-12-16 | 2005-05-03 | Agency For Science, Technology And Research | Bacterial-derived molecules and therapeutic and diagnostic uses therefor |
| GB0028122D0 (en) | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| EP1996235A1 (en) * | 2006-02-21 | 2008-12-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Polypeptides, pharmaceutical compositions and methods for the prevention and the therapeutic treatment of inflammatory disorders |
| GB0803369D0 (en) * | 2008-02-25 | 2008-04-02 | Helperby Therapeutics Ltd | Biological materials and uses thereof |
| WO2010006059A1 (en) * | 2008-07-08 | 2010-01-14 | Abbott Laboratories | Prostaglandin e2 binding proteins and uses thereof |
-
2011
- 2011-10-21 GB GBGB1118201.1A patent/GB201118201D0/en not_active Ceased
-
2012
- 2012-10-19 CA CA2852381A patent/CA2852381C/en active Active
- 2012-10-19 ES ES12775541T patent/ES2770438T3/es active Active
- 2012-10-19 EP EP12775541.1A patent/EP2768850B1/en active Active
- 2012-10-19 WO PCT/GB2012/052586 patent/WO2013057499A1/en not_active Ceased
- 2012-10-19 JP JP2014536330A patent/JP6199296B2/ja active Active
-
2014
- 2014-05-14 US US14/120,259 patent/US9320791B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014532395A5 (https=) | ||
| Yi | Regulatory roles of the caspase-11 non-canonical inflammasome in inflammatory diseases | |
| Wawrocki et al. | Interleukin 18 (IL-18) as a target for immune intervention | |
| AU2006243994B2 (en) | Nebulization of monoclonal antibodies for treating pulmonary diseases | |
| JP2011528332A5 (https=) | ||
| Pandey et al. | Immunobiology of Toll‐like receptors: emerging trends | |
| CN102596992B (zh) | 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途 | |
| CN101965361B (zh) | 生物材料及其应用 | |
| JP2014525752A5 (https=) | ||
| JP2015517489A5 (https=) | ||
| JP2015501656A5 (https=) | ||
| JP2025032107A (ja) | 結核菌シャペロニン６０．１ペプチドおよびその使用 | |
| JP6199296B2 (ja) | 新規ペプチド | |
| JP2011528332A (ja) | 哺乳動物ベータ・デフェンシンを用いた炎症性疾患の処置 | |
| Sun et al. | Interleukin-8 of Cynoglossus semilaevis is a chemoattractant with immunoregulatory property | |
| HRP20161305T1 (hr) | Liječenje mikrobnih infekcija | |
| JP2015164424A5 (https=) | ||
| JP2025013922A (ja) | 肺の炎症性疾患を処置するための方法 | |
| Kurup et al. | Animal models of allergic bronchopulmonary aspergillosis | |
| TW201138810A (en) | Treatment of inflammatory bowel diseases with mammal beta defensins | |
| JP2005102701A5 (https=) | ||
| JP6158712B2 (ja) | 新規合成ペプチド及びそれらの使用 | |
| JP2017536124A5 (https=) | ||
| JP2018502579A5 (https=) | ||
| IL308645A (en) | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies |